The answer to the question "But, is it obvious?" is of fundamental importance to the validity of chemical and life sciences patents. In this seminar we will consider how this question is answered in the United States and Europe. We will discuss how to obtain patents that have the best chance of surviving obviousness challenges.  

Topics to be discussed include:

Can you use the same approach to establish inventive step before the EPO and non-obviousness before the USPTO?  And how about before the courts in Europe and in the United States?

The skilled person – who are they and what do they know?

Experimental data – how can it be used in support of inventive step/ non-obviousness?

This is the fifth of the five-part Finnegan European Prosecution Webinar series.

Scheduling Conflict? Finnegan records all hosted webinars. To view the recorded program, simply register for the webinar and you will receive an access link shortly after the live program is complete.

*Register

Moderator:
Anthony Tridico

Speakers:
Michele Bosch
Maeve O'Flynn

Date:
Thursday, 20 January 

Time:
15:00-16:00 GMT
16:00-17:00 CET
10:00-11:00 a.m. EST

*Note, these are personal RSVP links. If you would like to invite others or send someone in your place, please  click here to register someone else.